Microwave Oven With Removable Storage Cassette in Dashboard of Motor Vehicle
A microwave oven adapted for use within a motor vehicle dashboard area. The microwave oven has a removable storage cassette, and slidable platforms for securing and serving containers of beverages and foods.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20100280256 | PROCESS FOR PREPARING TRIAZOLONES The present process provides a improved method for the preparation of alkylsulfanyl substituted triazoles 2 which are useful intermediates in a new process for the preparation of triazolones 20. ... | 11/04/2010 |
| 20100272677 | HETEROCYCLIC ANTIVIRAL COMPOUNDS Compounds having the formula I wherein R1, R2, R3, R4, R5a, R5b, R5c and R6 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions an... | 10/28/2010 |
| 20100160388 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are m... | 06/24/2010 |
| 20100160384 | DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, p, q, R1, R2, R3, R4, R5 and R6 are as defined herein.... | 06/24/2010 |
| 20100160360 | JNK MODULATORS Compounds of formula I modulate JNK: wherein
| |
| 20100144758 | AZAINDOLE P2X3 AND P2X2/3 MODULATORS The application discloses compounds of the Formula I: or a pharmaceutically acceptable salt thereof, wherein, X, R1, R2 R3, R4, R5, R6, R... | 06/10/2010 |
| 20100068698 | PRODUCTION OF INFECTIOUS HEPATITIS C VIRUS PARTICLES IN CELL CULTURE The present invention provides for novel methods of producing high levels of infectious HCV genotype 1 virus particles in cell culture systems. The availability of HCV genotype 1 virus (principally associated with liver disease in most regions of the world) that can und... | 03/18/2010 |
| 20100063154 | POLYMORPHS OF ACYL SULFONAMIDES The application discloses novel polymorphic crystalline forms of 2-[4-Bromo-3-(3-chloro-5-cyano-phenoxy)-2-fluoro-phenyl]-N-(2-chloro-4-propionylsulfamoyl-phenyl)-acetamide, sodium salt (Ib) with improved sta... | 03/11/2010 |
| 20100056499 | 3-AMINO-1-ARYLPROPYL AZAINDOLES AND USES THEREOF The present invention provides compounds of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, | 03/04/2010 |
| 20100041648 | METHODS FOR TREATING RETROVIRAL INFECTIONS The present invention provides compositions for treating an HIV infection comprising administering a compound according to formula I where Ar, R1-R5, R11c and X1 are as defined herein with at least one carrier, excipient or di... | 02/18/2010 |
| 20090197934 | IMIDAZOLINYLMETHYL ARYL SULFONAMIDE This invention relates to an alpha-1A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical co... | 08/06/2009 |
| 20090197933 | IMIDAZOLINYLMETHYL ARYL SULFONAMIDE This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical c... | 08/06/2009 |
| 20090197932 | IMIDAZOLINYLMETHYL ARYL SULFONAMIDE This invention relates to an alpha-1A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical co... | 08/06/2009 |
| 20090197931 | IMIDAZOLINYLMETHY ARYL SULFONAMIDE This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical c... | 08/06/2009 |
| 20090170874 | Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted triazolyl, and R2, R3, R4, R5, R6 | |
| 20090170873 | Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted pyrazolyl, and R2, R3, R4, R5, R6 | |
| 20090163499 | Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonists Compounds of the formula I: wherein R1 is optionally substituted imidazolyl, and R2, R3, R4, R5, R6, R7 and R8 are as de... | 06/25/2009 |